Pragmatic trial on inhaled corticosteroid withdrawal in patients with COPD in general practice

The therapeutic value of inhaled corticosteroids (ICSs) for COPD is limited. In published RCTs, ICS could be withdrawn in COPD patients without increasing exacerbation risk when bronchodilator treatment is optimized. Here we report on the feasibility and risks of ICS withdrawal in Dutch general prac...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:NPJ Prim Care Respir Med
Main Authors: van den Bemt, Lisette, van den Nieuwenhof, Lotte, Rutjes, Anne, van der Meer, Victor, Stege, Gerben, Wensing, Michel, Teichert, Martina, Schermer, Tjard
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7547069/
https://ncbi.nlm.nih.gov/pubmed/33037200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41533-020-00198-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares